|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ABCG2 : a perspective 显示文摘 | Robey RW To KK Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 2 | A functional assay for detection of the mitoxantrone resistance protein, MXR ( ABCG2 ) 显示文摘 | Robey RW Honjo Y Miyake K | 2001 | Biochim Bionhys Acta2001，1512，2： | 1 |
| 3 | ABCG2:a perspe-ctive显示文摘 | Robey RW To KK Polgar O | | 0，，01： | 1 |
| 4 | The role of half-transporter in multidrug resistance 显示文摘 | Bates SE Robey RW Miyake K | 2001 | J Bioenerg Biomembr2001，33，： | 1 |
| 5 | ABCG2-mediated transport of photosensitizers:potential impact on photodynamic therapy显示文摘 | Robey RW Steadman K Polgar O | 2005 | Cancer Biol Ther2005，4，2： | 1 |
| 6 | ABCG2: a perspective显示文摘 | Robey RW To KK Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 7 | Pheophorbide a is a specific probe for ABCG2 function and inhibition 显示文摘 | Robey RW Steadman K Polgar O | 2004 | Cancer Res2004，64，4： | 1 |
| 8 | Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide(FR901228,FK228,NSC630 176)显示文摘 | Robey RW Zhan Z Pickarz RL | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 9 | A functional assay for detection of the mitoxantrone resistance protein,MXR(ABCG2)显示文摘 | Robey RW Honjo Y van de Laar A | 2001 | Biochim Biophys Acta2001，1512，2： | 1 |
| 10 | ABCG2: structure, function and role in drug response显示文摘 | Polgar O Robey RW Bates SE | 2008 | Expert Opin Drug Metab Toxicol2008，4，1： | 1 |
| 11 | ABCG2 :determining its relevance in clinical drug resistance 显示文摘 | Robey RW Polgar O Deeken J | 2007 | Cancer Metastasis Rev2007，26，1： | 1 |
| 12 | A functional assay for detection of the mitoxantrone resistance protein,MXR (ABCG2)显示文摘 | Robey RW Honjo Y van de Laar A | 2001 | Biochimicaet Biophysica Acta2001，1512，： | 1 |
| 13 | A function assay for de- tection of the mitoxantrone resistance protein MXR (ABCG2) 显示文摘 | Robey RW Honjo Y Van de Laar A | 2001 | Biochim Biophys Acta2001，1512，2： | 1 |
| 14 | ABCG2: a perspective显示文摘 | Robey RW To KK Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 15 | ABCG2: Structure, function and role in drug response 显示文摘 | Polgar O Robey RW Bates SE | 2008 | Expert Opin Drug Metab Toxicol2008，4，： | 1 |
| 16 | Reduced expression of DNA topoisomerase Ⅰ in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan显示文摘 | Liao Z Robey RW Guirouilh-Barbat J | | 0，，： | 1 |
| 17 | ABCG2 : a perspective 显示文摘 | Robey RW To KK Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 18 | ABC trans- porters: unvalidated therapeutic targets in cancer and the CNS 显示文摘 | Robey RW Masse) PR Amiri - Kordestani L | 2010 | Anticancer Agents Med Chem2010，10，： | 1 |
| 19 | Phase Ⅰ trial of the histone deacetylase inhibitor, depsipeptide ( FR901228, NSC 630176), in patients with refractory neoplasms显示文摘 | Bakke S Robey RW | 2002 | Clin Cancer Res2002，8，3： | 1 |
| 20 | Single nucleotide polymorphisms modify the transporter activity of ABCG2 显示文摘 | Morisaki K Robey RW Zvegy Laczka C | 2005 | Cancer Chemother Pharm2005，56，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员